UBD and neoplasm: Since mutations found in the promoter region had been correlated with the overexpression of genes in cancer cells [25,45], we sequenced ~1.3 kb of the FAT10 promoter region from a tumor and the adjacent non-tumorous liver tissues of 37 HCC patients to screen for mutations.